HOME >> BIOLOGY >> NEWS
University of Pittsburgh receives $10 million grant for head and neck cancer

PITTSBURGH, Aug. 26 The University of Pittsburgh Cancer Institute (UPCI) has received a five-year, $10 million Specialized Program of Research Excellence (SPORE) federal grant to examine innovative treatment strategies designed to improve survival outcomes for patients with head and neck cancer. The grant, awarded by the National Cancer Institute (NCI), is the second SPORE awarded to UPCI the first was awarded to the cancer institute's Lung Cancer Program in 2001 and is one of only four SPORE grants in head and neck cancer awarded nationally.

"Head and neck cancer is one of the most physically and emotionally debilitating cancers," said Jennifer Grandis, M.D., principal investigator of the grant and professor of otolaryngology and pharmacology, University of Pittsburgh School of Medicine, and director of UPCI's Head and Neck Cancer Program. "Treatment options are limited and often leave a patient with disabling side effects that can have a devastating impact on quality of life. This grant will enable us to enhance the quality of life for head and neck cancer patients and greatly improve their prognoses through the collaborative efforts of our researchers in the laboratory and clinic."

The grant funds four major translational research projects that focus on genetic changes that are potential risk factors for head and neck cancer, intracellular signaling proteins activated during head and neck cancer, and new treatment strategies designed to reduce the morbidity and mortality from head and neck cancer.

According to Dr. Grandis, each project within the grant has two co-leaders, one with expertise in basic or laboratory science and the other with expertise in clinical research and care. By integrating laboratory findings with clinical research and epidemiological data, Dr. Grandis expects study results to be more rapidly disseminated to cancer patients. The grant also includes input from patient advocates who will focus on research-related
'"/>


26-Aug-2004


Page: 1 2 3

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. Clemson University spin-off uses corn to make plastics, provide cleaner air
11. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... services, today announced that the company has received ISO9001:2015 certification for the ... and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment ...
(Date:6/23/2020)... TORONTO (PRWEB) , ... June 22, 2020 , ... The ... time. Typically, ligand binding assays (LBA) have dominated this area. However, the use of ... several years. , This now necessitates the question “How do you choose which approach ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering ... 50 million stem cells total, patients may choose which extremities they would like treated. ... joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... Join experts ... John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... the regulating body in China for drugs and medical devices. Specifically, for medical devices, ...
(Date:7/18/2020)... ... 2020 , ... dicentra , a leading Contract Research ... is pleased to announce that Charles Galea has joined its clinical trials division ... an accomplished and results-driven sales executive with over 10 years of expertise in ...
Breaking Biology Technology:
Cached News: